Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.50 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.50 |
| ▸ | ABCC1 | P33527 | 3/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | F10 | P00742 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | CASP1 | P29466 | 2/20 | 0.44 |
| ▸ | CASP7 | P55210 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20581904 | 0.95 | ADORA3 (0.54) | KDM4ECYP3A4ABCG2MEN1MAPK1 | |
| SCHEMBL24345688 | 0.91 | ADORA3 (0.50) | KDM4ECYP3A4ABCG2MEN1MAPK1 | |
| SCHEMBL20581913 | 0.87 | ADORA3 (0.53) | KDM4ECYP3A4ABCG2MEN1MAPK1 | |
| SCHEMBL22076468 | 0.87 | ADORA3 (0.59) | KDM4ECYP3A4ABCG2MEN1MAPK1 | |
| SCHEMBL20581836 | 0.85 | ADORA3 (0.55) | KDM4ECYP3A4ABCG2MEN1MAPK1 | |
| SCHEMBL23117590 | 0.85 | ADORA3 (0.51) | KDM4ECYP3A4ABCG2MEN1MAPK1 | |
| SCHEMBL22076430 | 0.85 | MAPT (0.59) | KDM4ECYP3A4ABCG2MEN1MAPK1 | |
| SCHEMBL8581588 | 0.84 | ADORA3 (0.50) | KDM4ECYP3A4ABCG2MEN1MAPK1 | |
| SCHEMBL11098925 | 0.84 | ABCG2 (0.72) | KDM4ECYP3A4ABCG2MEN1MAPK1 | |
| SCHEMBL20581896 | 0.83 | ADORA3 (0.49) | KDM4ECYP3A4ABCG2MEN1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220110960-A1 | ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2022-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220110960-A1 | ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS | ENPP2, MBOAT7, AADAC | KDM4E 2430/4885CYP3A4 4519/4885ABCG2 4677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.